Changshan Pharmaceutical (300255.SZ) released results for the first three quarters, with a net loss of 378.944 million yuan

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Changshan Pharmaceutical (300255.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 736 million yuan, an increase of 8.10% over the previous year. The net loss attributable to shareholders of listed companies was 378.944 million yuan. Net loss of 42.6015 million yuan for non-recurring profit and loss attributable to shareholders of listed companies is deducted.